Michael Courtney
No más puestos en curso
Perfil
Michael Courtney served as Chairman & CEO of Aptanomics SA in 2008, President & CEO of Imaxio SA, and President of CellVir SAS.
He received an undergraduate degree from the University of Glasgow and a doctorate degree from the University of London.
Antiguos cargos conocidos de Michael Courtney.
| Empresas | Cargo | Fin |
|---|---|---|
CellVir SAS
 CellVir SAS Pharmaceuticals: OtherHealth Technology CellVir SAS develops anti-retrovirals based on novel therapeutics. Its research is focused on HIV disease. The company was founded by Richard Benarous, Richard Platford, Armand Frydman, E. Thomas Bader, and Jean Deregnaucourt on March 20, 2006 and is headquartered in Evry, France. | Presidente | 04/06/2012 |
Aptanomics SA
 Aptanomics SA Pharmaceuticals: MajorHealth Technology Aptanomics SA discovers and develops new drugs in major markets of unmet medical need. Its proprietary discovery engine, based on peptide aptamers, delivers a regular flow of new hits against relevant industrial targets. Aptanomics offers opportunities for drug discovery collaborations leveraging the peptide aptamer technology to identify new druggable sites and screen for small molecule hits. The company was founded by Roger Brent, Pierre Colas and Johm B. Hawken in 2001 and is headquarters in Lyon, France | Presidente | 24/01/2008 |
Imaxio SA
 Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Presidente | - |
Formación de Michael Courtney.
| University of Glasgow | Undergraduate Degree |
| University of London | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Aptanomics SA discovers and develops new drugs in major markets of unmet medical need. Its proprietary discovery engine, based on peptide aptamers, delivers a regular flow of new hits against relevant industrial targets. Aptanomics offers opportunities for drug discovery collaborations leveraging the peptide aptamer technology to identify new druggable sites and screen for small molecule hits. The company was founded by Roger Brent, Pierre Colas and Johm B. Hawken in 2001 and is headquarters in Lyon, France | Health Technology |
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Health Technology |
CellVir SAS
CellVir SAS Pharmaceuticals: OtherHealth Technology CellVir SAS develops anti-retrovirals based on novel therapeutics. Its research is focused on HIV disease. The company was founded by Richard Benarous, Richard Platford, Armand Frydman, E. Thomas Bader, and Jean Deregnaucourt on March 20, 2006 and is headquartered in Evry, France. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Courtney
